Join the Paliperidone group to help and get support from people like you.
Paliperidone News
Related terms: Paliperidone Palmitate
Long-Acting Injected Antipsychotics Help People With Schizophrenia Stay Out of Hospital
WEDNESDAY, Jan. 31, 2024 – For people with schizophrenia hospitalized after a psychotic episode, getting a long-acting antipsychotic injection works far better than pills to keep them from returning...
FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia
TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic ...
FDA Medwatch Alert: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure
ISSUE: Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A,...
FDA Approves Invega Trinza (paliperidone palmitate) Four-Times-A-Year Treatment for Schizophrenia
TITUSVILLE, N.J., May 19, 2015 – There’s a new treatment option for schizophrenia – Invega Trinza (three-month paliperidone palmitate), the first and only schizophrenia medication to be administered j...
FDA Approves sNDA for Invega Sustenna (paliperidone palmitate) for Schizoaffective Disorder
TITUSVILLE, N.J., Nov. 13, 2014 /PRNewswire/ – Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Applications (sNDAs)...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Schizoaffective Disorder, Schizophrenia, Borderline Personality Disorder, Autism, Bipolar Disorder, Depression